Shabeeha Rana, Consultant Hematologist at King’s College Hospital London – UAE, Adjunct Clinical Assistant Professor at University of Sharjah, shared a post on LinkedIn:
“I am delighted to share our latest publication:
‘Risk Assessment and Management of Thromboembolism in Cancer Patients: A Single-Centre Retrospective Study.’
Cancer-associated thrombosis remains one of the leading causes of morbidity and mortality in patients with cancer. Early recognition of thromboembolic risk, timely diagnosis, and evidence-based management are essential to improving patient outcomes.
This study reinforces the importance of proactive risk assessment and highlights the value of a multidisciplinary approach, bringing together oncology, haematology, pharmacy, nursing, and allied healthcare professionals to deliver optimal patient care.
I am especially proud that this project was led by a Research Intern at King’s College Hospital Dubai, demonstrating the impact that early research opportunities and strong mentorship can have in advancing clinical practice. It has been a privilege to support a project that not only contributes to the growing evidence base in cancer-associated thrombosis but also showcases the talent and dedication of our emerging clinical researchers.
A sincere thank you to all co-authors, mentors, and collaborators whose expertise and commitment made this work possible. I hope these findings encourage continued efforts to improve awareness, risk stratification, and multidisciplinary management of thromboembolism in patients with cancer.”
Other articles about Hematology on OncoDaily.